Autopsy report · NCT05675319
Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy
Cause of deathFunding or business
“The reason for the end of recruitment is that the recruitment target could not be achieved despite all efforts and the G-BA (financing party) does not consider a continuation of the AlloRelapseMM study to be expedient.”
Life of this trial
- Registered 4 months before it started.
- Ran for about 2 years 1 month before it stopped.
- 28 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Sponsor type
- University, hospital or other
- Conditions
- Multiple Myeloma
- Interventions
- Allogeneic Stem Cells; carfilzomib/lenalidomide/dexamethasone (KRD); elotuzumab/lenalidomide/dexamethasone (ERD); daratumumab/bortezomib/dexamethasone (DVD); daratumumab/lenalidomide/dexamethasone (DRD); ixazomib/lenalidomide/dexamethasone (IRD)
- Participants
- 28
- Sites
- 30
- Countries
- Germany
Trials that died the same way
- High-intensity Exercise After Acute Cardiac Event (HITCARE)
“Recruitment was stopped due to lack of funding.” - A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
“The recruitment was halted for strategic reasons” - Digital Prevention of Asthma
“The recruitment stopped due insufficient funding.” - A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
“end of recruitment” - Study of Vascular Function Before vs After Smoking an E-cigarette as Compared to a Normal Cigarette
“due to recruitment reasons the study was prematurely ended”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.